TAVRcathAID vs Cordis@hand
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
TAVRcathAID
This educational tool provides step-by-step guidance for performing diagnostic coronary angiograms and percutaneous coronary interventions after trans-catheter aortic valve implantation. It features illustrations and animations to aid in understanding complex procedures.
- Step-by-step procedural guidance
- Illustrations and animations
- Focus on post-TAVR interventions
- Diagnostic coronary angiogram guide
- Percutaneous coronary intervention guide
Read full descriptionHide full description
The TAVR CathAID app team comprises of interventional and structural cardiology faculty and fellows at Icahn School of Medicine at Mount Sinai. This app is an educational tool with step by step approach guided by illustrations and aminations to perform diagnostic coronary angiogram and percutaneous coronary intervention after implantation of trans-catheter aortic valve.
Cordis@hand
This interventional education app provides procedural modules for coronary and endovascular learning. Users can expand their skills and master specific tools through interactive learning or self-testing. Access educational content anytime, anywhere.
- Procedural learning modules
- Coronary and endovascular training
- Skill expansion
- Tool mastery
- Self-testing options
- On-demand access
Read full descriptionHide full description
Cordis@hand is an interventional education app that puts learning in your hands. Through a series of procedurally based coronary and endovascular modules, users can expand their skills and master Cordis tools. Learn or test yourself. Available whenever, wherever. Please contact us for support at: srqcustomerservice@cae.com
Screenshots
Verdict
The clearest difference is rating: Cordis@hand at 4.9 against TAVRcathAID's 4.6. Cordis@hand also leads on ratings volume (35 vs 5) and iOS requirement (10.0 vs 15.0). TAVRcathAID's advantage is update cadence (fortnightly vs every 5 weeks). On price, ads, in-app purchases and monetization model there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Cordis@hand holds the better App Store score, 4.9 against 4.6. That said, the two scores are not equally well evidenced: Cordis@hand has 35 ratings behind it against 5, so its average is the more settled of the two.
TAVRcathAID ships an update fortnightly, Cordis@hand every 5 weeks. The most recent releases landed on November 16, 2026 and November 7, 2026 respectively.
| Parameter | TAVRcathAID | Cordis@hand |
|---|---|---|
| Price | Free | Free |
| Rating | 4.6 (5 ratings) | 4.9 (35 ratings) — better |
| Positive reviews | — | 100.0% of reviews |
| Number of ratings | 5 | 35 — better |
| Update frequency | Fortnightly — better | Every 5 weeks |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 15.0 | 10.0 — better |
| Further details — not scored | ||
| Size | 49 MB | 505 MB |
| Age rating | 17+ | 17+ |
| Developer | Icahn School of Medicine at Mount Sinai | Cardinal Health, Inc |
Customer experience
TAVRcathAID
Cordis@hand
In-app purchases
TAVRcathAID
No in-app purchases
Cordis@hand
No in-app purchases









